Acamprosate suppresses ethanol-induced place preference in mice with ethanol physical dependence

Journal of Pharmacological Sciences

Volumn 122, Issue 4, 2013, Pages 289-298

  Kurokawa, Kazuhiro ^a   Mizuno, Koji ^a   Shibasaki, Masahiro ^a,c   Higashioka, Masaya ^b   Oka, Michiko ^b   Hirouchi, Masaaki ^b   Ohkuma, Seitaro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b NIPPON SHINYAKU CO LTD   (Japan)

^c HOSHI UNIVERSITY   (Japan)

Author keywords

Acamprosate; Alcohol dependence; Conditioned place preference; Ethanol; Phospho cAMP response element binding protein (p CREB)

Indexed keywords

ACAMPROSATE; ALCOHOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FOREBRAIN; LIMBIC CORTEX; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE;

ADMINISTRATION, INHALATION; ALCOHOL DETERRENTS; ALCOHOLISM; ANIMALS; CONDITIONING (PSYCHOLOGY); CREB-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; INJECTIONS, INTRAPERITONEAL; LIMBIC SYSTEM; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; TAURINE;

EID: 84883343018     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.13056FP     Document Type: Article

References (44)

1. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci. 2005;8:1445-1449. (Pubitemid 41573654)
2. Vanderschuren LJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl). 2000;151:99-120. (Pubitemid 30646415)
3. Foddai M, Dosia G, Spiga S, Diana M. Acetaldehyde increases dopaminergic neuronal activity in the VTA. Neuropsychopharmacology. 2004;29:530-536. (Pubitemid 38365929)
4. Ding ZM, Rodd ZA, Engleman EA, McBride WJ. Sensitization of ventral tegmental area dopamine neurons to the stimulating effects of ethanol. Alcohol Clin Exp Res. 2009;33:1571-1581.
5. Yoshimoto K, McBride WJ, Lumeng L, Li TK. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol. 1992;9:17-22.
6. Shibasaki M, Kurokawa K, Mizuno K, Ohkuma S. Effect of aripiprazole on anxiety associated with ethanol physical dependence and on ethanol-induced place preference. J Pharmacol Sci. 2012;118:215-224.
7. Shibasaki M, Kurokawa K, Mizuno K, Suzuki T, Ohkuma S. Actin dynamics in development of behavioral sensitization after withdrawal from long-term ethanol administration to mice. Alcohol Clin Exp Res. 2012;36:1385-1396.
8. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci. 2001;21:7397-7403. (Pubitemid 32846987)
9. Robison AJ, Nestler EJ. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci. 2011;12:623-637.
10. Dong Y, Green T, Saal D, Marie H, Neve R, Nestler EJ, et al. CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci. 2006;9:475-477.
11. Pandey SC, Roy A, Zhang H, Xu T. Partial deletion of the cAMP response element-binding protein gene promotes alcohol- drinking behaviors. J Neurosci. 2004;24:5022-5030. (Pubitemid 38697836)
12. Yang X, Horn K, Wand GS. Chronic ethanol exposure impairs phosphorylation of CREB and CRE-binding activity in rat striatum. Alcohol Clin Exp Res. 1998;22:382-390. (Pubitemid 28208961)
13. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2001;2:119-128. (Pubitemid 33673366)
14. Shibasaki M, Mizuno K, Kurokawa K, Ohkuma S. Enhancement of histone acetylation in midbrain of mice with ethanol physical dependence and its withdrawal. Synapse. 2011;65:1244-1250.
15. Daoust M, Legrand E, Gewiss M, Heidbreder C, DeWitte P, Tran G, et al. Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats. Pharmacol Biochem Behav. 1992;41:669-674.
16. Witkiewitz K, Saville K, Hamreus K. Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility. Ther Clin Risk Manag. 2012;8:45-53.
17. Hinton DJ, Lee MR, Jacobson TL, Mishra PK, Frye MA, Mrazek DA, et al. Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1. Neuropharmacology. 2012;62:2480-2488.
18. Chau P, Stomberg R, Fagerberg A, Soderpalm B, Ericson M. Glycine receptors involved in acamprosate's modulation of accumbal dopamine levels: an in vivo microdialysis study. Alcohol Clin Exp Res. 2010;34:32-38.
19. Rosner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Database Syst Rev. 2010:CD004332.
20. Bouza C, Angeles M, Munoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction. 2004;99:811-828. (Pubitemid 38869838)
21. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295:2003-2017. (Pubitemid 44794003)
22. Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N, et al. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction. 2006;101:1451-1462. (Pubitemid 44337770)
23. Mason BJ, Goodman AM, Chabac S, Lehert P. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J Psychiatr Res. 2006;40:383-393. (Pubitemid 43816589)
24. McGeehan AJ, Olive MF. The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine. Br J Pharmacol. 2003;138:9-12. (Pubitemid 36194197)
25. Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P. Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol. 1991;26:129-137.
26. Heyser CJ, Schulteis G, Durbin P, Koob GF. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology. 1998;18:125-133. (Pubitemid 28026682)
27. Lee MR, Hinton DJ, Wu J, Mishra PK, Port JD, Macura SI, et al. Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1. Neurosci Lett. 2011;490:90-95.
28. Goldstein DB. Relationship of alcohol dose to intensity of withdrawal signs in mice. J Pharmacol Exp Ther. 1972;180:203-215.
29. Shibasaki M, Inoue M, Kurokawa K, Ogou S, Ohkuma S. Expression of serotonin transporter in mice with ethanol physical dependency. J Pharmacol Sci. 2010;114:234-237.
30. Kurokawa K, Mizuno K, Ohkuma S. Dopamine D1 receptor signaling system regulates ryanodine receptor expression in ethanol physical dependence. Alcohol Clin Exp Res. 2013;37:771-783.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
32. Pandey SC, Roy A, Mittal N. Effects of chronic ethanol intake and its withdrawal on the expression and phosphorylation of the creb gene transcription factor in rat cortex. J Pharmacol Exp Ther. 2001;296:857-868. (Pubitemid 32187358)
33. Lessov CN, Phillips TJ. Duration of sensitization to the locomotor stimulant effects of ethanol in mice. Psychopharmacology (Berl). 1998;135:374-382. (Pubitemid 28254844)
34. Lack AK, Diaz MR, Chappell A, DuBois DW, McCool BA. Chronic ethanol and withdrawal differentially modulate pre- and postsynaptic function at glutamatergic synapses in rat basolateral amygdala. J Neurophysiol. 2007;98:3185-3196.
35. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science. 1997;278:58-63. (Pubitemid 27446271)
36. Mason BJ, Heyser CJ. Acamprosate: a prototypic neuro modulator in the treatment of alcohol dependence. CNS Neurol Disord Drug Targets. 2010;9:23-32.
37. Chandler LJ, Newsom H, Sumners C, Crews F. Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons. J Neurochem. 1993;60:1578-1581. (Pubitemid 23088340)
38. Hoffman PL, Tabakoff B. The role of the NMDA receptor in ethanol withdrawal. EXS. 1994;71:61-70.
39. Nagy J. Alcohol related changes in regulation of NMDA receptor functions. Curr Neuropharmacol. 2008;6:39-54. (Pubitemid 351513472)
40. Lynch WJ, Taylor JR. Persistent changes in motivation to self-administer cocaine following modulation of cyclic AMP-dependent protein kinase A (PKA) activity in the nucleus accumbens. Eur J Neurosci. 2005;22:1214-1220. (Pubitemid 41395386)
41. Beninger RJ, Nakonechny PL, Savina I. cAMP-dependent protein kinase and reward-related learning: intra-accumbens Rp-cAMPS blocks amphetamine-produced place conditioning in rats. Psychopharmacology (Berl). 2003;170:23-32. (Pubitemid 37372475)
42. Ahern KB, Lustig HS, Greenberg DA. Enhancement of NMDA toxicity and calcium responses by chronic exposure of cultured cortical neurons to ethanol. Neurosci Lett. 1994;165:211-214. (Pubitemid 24043278)
43. Ehlers MD. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci. 2003;6:231-242. (Pubitemid 36278281)
44. Nona CN, Guirguis S, Nobrega JN. Susceptibility to ethanol sensitization is differentially associated with changes in pCREB, trkB and BDNF mRNA expression in the mouse brain. Behav Brain Res. 2013;242:25-33.